| Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays. | |
| | |
MedLine Citation:
|
PMID: 12164375 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The ability of a drug to penetrate the blood-brain barrier (BBB) is essential for its use in the pharmaceutical treatment of CNS disorders. Five different in vitro methods to predict BBB permeability of drugs were compared and evaluated in the present study. All assays were performed with a consistent set of seven compounds and in the same physiological buffer to provide a basis for direct comparison of the results. Octanol-buffer and liposome-buffer partition coefficients were most conveniently obtained but failed to predict BBB permeability for certain drugs. The incorporation of drugs into lipid monolayers at the air-buffer interface was found to be a poor predictor of BBB permeability and was furthermore not considered suitable for screening due to the demanding experimental requirements. Permeability studies using Caco-2 cell monolayers provided a good correlation to an in vitro model of the BBB, which was based on primary cultured porcine brain capillary endothelial cells (PBCEC). However, differences in drug permeability between the intestine and brain derived cells were detected, limiting the advantages of the easy handling of the Caco-2 cell line compared to the more time-consuming primary culture of the BCEC. |
| | |
Authors:
|
C Lohmann; S Hüwel; H J Galla |
Related Documents
:
|
22028505 - Aloe vera: nature's soothing healer to periodontal disease. 18582565 - Comparison of nanosuspensions and hydroxypropyl-beta-cyclodextrin complex of melarsopro... 15936515 - The anti-parkinson drug budipine is exported actively out of the brain by p-glycoprotei... 2900315 - Differential displacement of opioids from plasma protein binding sites by di-isopropylf... 6512675 - Relationship between the anti-inflammatory effects and intrapleural accumulations of an... 2883885 - Famotidine. the acg committee on fda-related matters with primary authorship by g. frie... |
Publication Detail:
|
Type: Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of drug targeting Volume: 10 ISSN: 1061-186X ISO Abbreviation: J Drug Target Publication Date: 2002 Jun |
Date Detail:
|
Created Date: 2002-08-07 Completed Date: 2002-12-23 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9312476 Medline TA: J Drug Target Country: England |
Other Details:
|
Languages: eng Pagination: 263-76 Citation Subset: IM |
Affiliation:
|
Institut für Biochemie, Westfälische Wilhelms-Universität Münster, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood-Brain Barrier / physiology* Caco-2 Cells Forecasting Humans Lipid Bilayers / metabolism Liposomes Membranes, Artificial* Permeability / drug effects Pharmaceutical Preparations / chemistry, metabolism* Rats |
| Chemical | |
Reg. No./Substance:
|
0/Lipid Bilayers; 0/Liposomes; 0/Membranes, Artificial; 0/Pharmaceutical Preparations |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Four cases of a secondary Cushingoid state following local triamcinolone acetonide (Kenacort) inject...
Next Document: Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-syst...